News

Dr. Srdan Verstovsek presents results from Ropeginterferon vs Hydroxyurea study at MPN Asia 2018

After a 2 year study, Ropeginterferon proves more effective than Hydroxyurea in symptom improvement and lowering progression rates

Free webinar for MPN patients and caregivers

NCCN to host 2 events focused on education

myMPN data shows trends for PV, ET and MF

Users with PV, ET and MF are entering symptom data across the country

MPN Alliance Australia and MPN Research Foundation Partner to support research

MPNAA and MPNRF work together to better understand interferon

Blood article by MD Anderson researchers looks back at 107 MF patients who discontinued Jakafi

Authors describe epigenetic mutations in some patients and suggest follow up research is needed

CR&T Shares videos from their 8th International MPN conference

Watch video updates from MPN experts

CTI Biopharma expands it's clinical Trial

CTI Biopharma is recruiting patients for the PAC203 study, a randomized phase 2 trial evaluating different doses of pacritinb in myelofibrosis patients. Previously, patients had to have a platelet count less than 100,000.

Recognizing some of the women in the MPN community

March 8th is International Women's Day

“Beyond Blue,” a short documentary by an award‐winning filmmaker, debuts to raise awareness of MPNs

Constellation Pharmaceuticals announced a Phase 2 study of CPI-0610 in patients with myelofibrosis.

Constellation Pharmaceuticals announced a Phase 2 study of CPI-0610 alone or in combination with ruxolitinib in patients with myelofibrosis.

Asana BioSciences Announces a Phase II trial in patients with MF

Asana BioSciences announces a Phase II study in patients with myelofibrosis is in progress in the US.

Read about the life of the Founder of MPNRF

Obituary for Robert Rosen, Founder of the MPN Research Foundation

Celgene buys maker of Fedratinib

Fedratinib may be approved for patients resistant to or intolerant of Jakafi

Two MPN experts discuss ASH 2017

Return of old drugs, update to prognostic scoring system and more

Video updates from ASH 2017

Four experts weigh in on the MPN updates